Melanie Kahl
Papers
2
Total Citations
21
H-Index
2
About
Melanie Kahl is a biomedical engineer advancing the frontier of high-throughput, reproducible 3D cell culture. Her research centers on developing open-source, automated platforms to overcome bottlenecks in hydrogel-based tissue engineering. Kahl’s most impactful contribution is the creation of a standardized, open-source technology platform for producing gelatin methacryloyl (GelMA) hydrogels—a widely used, bioactive material that combines natural gelatin with photo-crosslinkable properties. Her 2021 paper on this platform (17 citations) directly addresses the field’s reliance on manual, time-consuming workflows, offering a scalable solution that enhances reproducibility and enables high-throughput production. Building on this, Kahl engineered a fluorescence-based opto-mechatronic screening module (OMSM) for automated 3D cell culture workflows (2023, 4 citations). This cost-effective system integrates with existing lab equipment to increase throughput and reduce user variability, sidestepping the limitations of traditional 3D bioprinters, which are often restricted to specific biomaterials and lack post-processing capabilities. By democratizing access to reproducible, tailorable hydrogels and automated screening, Kahl’s work is empowering researchers to conduct more reliable, scalable studies in tissue engineering and drug discovery.
Research Focus
Key Achievements
Top Papers
- 1
- 2